Author

Yasamin Majedi

Lady Davis Institute for Medical ResearchORCID 0000-0001-8445-0348Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adriana Aguilar‐MahechaiD· 1 shared Anie MonastiD· 1 shared Benjamin UlmeriD· 1 shared Catherine ChabotiD· 1 shared Eric BarekeiD· 1 shared Geneviève MoriniD· 1 shared Hellen KuasneiD· 1 shared Juliet GuayiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adriana Aguilar‐MahechaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ATR and PKMYT1 inhibition re-sensitize a subset of TNBC patient-derived models to carboplatin inducing mitotic catastrophe

Juliet Guay, Hellen Kuasne, Catherine Chabot, Kathryn Bozek, Yasamin Majedi, Marguerite Buchanan, Adriana Aguilar‐Mahecha, Eric Bareke, Benjamin Ulmer, Tim Kong, Kangning Yang, Minyan Liao, Oluwadara O. Elebute, Ruining Guo, Anie Monast, , Mark Basik

This study identifies ATR and PKMYT1 as targets to overcome carboplatin resistance in TNBC by re-sensitizing resistant models to carboplatin through mitotic catastrophe.

Cancer Research Communications · Apr 13, 2026Peer-reviewedCancer Biology